DEUTETRABENAZINE | N216354 | TEVA NEUROSCIENCE INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2021-01507 | 8524733 | IPR | Apotex Inc. et al. | Institution Denied | 2021-09-08 | 2022-03-09 |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
TEVA NEUROSCIENCE, INC. et al v. ALKEM LABORATORIES LIMITED et al 12 patentsANDA 221495deutetrabenazine | D.N.J. | 2026-06-05 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$502.29
per ea
Lowest NADAC/Unit
$83.72
per ea
Brand NDCs
9
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68546047656AUSTEDO XR 48 MG TABLET | $502.29 | EA | Brand | — | 2026-06-17 |
| 68546047556AUSTEDO XR 42 MG TABLET | $499.25 | EA | Brand | — | 2026-06-17 |
| 68546047456AUSTEDO XR 36 MG TABLET | $421.08 | EA | Brand | — | 2026-06-17 |
| 68546047356AUSTEDO XR 30 MG TABLET | $333.22 | EA | Brand | — | 2026-06-17 |
| 68546047956AUSTEDO XR 18 MG TABLET | $251.07 | EA | Brand | — | 2026-06-17 |
| 68546047256AUSTEDO XR 24 MG TABLET | $250.39 | EA | Brand | — | 2026-06-17 |
Showing 6 of 9 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8524733 | Apr 3, 2031PED: Oct 3, 2031 | PED | Yes | Yes | — | — |
| 9550780 | Sep 18, 2033PED: Mar 18, 2034 | PED | Yes | Yes | — | |
| 10959996 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 11179386 | Mar 15, 2038PED: Sep 15, 2038 | PED | — | Yes | — | |
| 11311488 | Jun 10, 2041 | — | — | Yes | — | |
| 11357772 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 11446291 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 11564917 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 11648244 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 11813232 | Mar 15, 2038PED: Sep 15, 2038 | PED | — | Yes | — | — |
| 12016858 | Mar 7, 2036PED: Sep 7, 2036 | PED | — | — | — | |
| 12589075 | Jun 10, 2041 | — | — | — | — | |
| 12599598 | Jun 10, 2041 | — | — | — | — |